Modern methods for delivery of drugs across the blood-brain barrier

被引:765
作者
Chen, Yan [1 ]
Liu, Lihong [2 ]
机构
[1] Curtin Univ Technol, Sch Pharm, CHIRI, WABRI, Perth, WA 6845, Australia
[2] Inst Bioengn & Nanotechnol, Singapore 138669, Singapore
关键词
Blood-brain barrier; Drug delivery; Receptor-mediated transport; Cell-mediated transport; Nanoparticles; Liposomes; Pathological conditions; CELL-PENETRATING PEPTIDES; CENTRAL-NERVOUS-SYSTEM; TIGHT JUNCTION PERMEABILITY; PLURONIC BLOCK-COPOLYMERS; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-C; IN-VITRO MODEL; EFFLUX TRANSPORTER ACTIVITY; NONTOXIC DIPHTHERIA-TOXIN; FACTOR MESSENGER-RNA;
D O I
10.1016/j.addr.2011.11.010
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The blood-brain barrier (BBB) is a highly regulated and efficient barrier that provides a sanctuary to the brain. It is designed to regulate brain homeostasis and to permit selective transport of molecules that are essential for brain function. Unfortunately, drug transport to the brain is hampered by this almost impermeable, highly selective and well coordinated barrier. With progress in molecular biology, the BBB is better understood, particularly under different pathological conditions. This review will discuss the barrier issue from a biological and pathological perspective to provide a better insight to the challenges and opportunities associated with the BBB. Modern methods which can take advantage of these opportunities will be reviewed. Applications of nanotechnology in drug transport, receptor-mediated targeting and transport, and finally cell-mediated drug transport will also be covered in the review. The challenge of delivering an effective therapy to the brain is formidable; solutions will likely involve concerted multidisciplinary approaches that take into account BBB biology as well as the unique features associated with the pathological condition to be treated. Crown Copyright (c) 2011 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:640 / 665
页数:26
相关论文
共 313 条
[1]
Astrocyte-endothelial interactions at the blood-brain barrier [J].
Abbott, NJ ;
Rönnbäck, L ;
Hansson, E .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) :41-53
[2]
Transporting therapeutics across the blood-brain barrier [J].
Abbott, NJ ;
Romero, IA .
MOLECULAR MEDICINE TODAY, 1996, 2 (03) :106-113
[3]
Dynamics of CNS barriers: Evolution, differentiation, and modulation [J].
Abbott, NJ .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2005, 25 (01) :5-23
[4]
Inflammatory mediators and modulation of blood-brain barrier permeability [J].
Abbott, NJ .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2000, 20 (02) :131-147
[5]
Adenot M, 2007, CHEMOTHERAPY, V53, P73, DOI 10.1159/000098422
[6]
Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes [J].
Afergan, Eyal ;
Epstein, Hila ;
Dahan, Rachel ;
Koroukhov, Nickolay ;
Rohekar, Keren ;
Danenberg, Haim D. ;
Golomb, Gershon .
JOURNAL OF CONTROLLED RELEASE, 2008, 132 (02) :84-90
[7]
REVERSIBLE MICROWAVE EFFECTS ON THE BLOOD-BRAIN-BARRIER [J].
ALBERT, EN ;
KERNS, JM .
BRAIN RESEARCH, 1981, 230 (1-2) :153-164
[8]
ANTIBODY-RESPONSES TO HEMOPHILUS-INFLUENZAE TYPE B AND DIPHTHERIA-TOXIN INDUCED BY CONJUGATES OF OLIGOSACCHARIDES OF THE TYPE-B CAPSULE WITH THE NONTOXIC PROTEIN CRM197 [J].
ANDERSON, P .
INFECTION AND IMMUNITY, 1983, 39 (01) :233-238
[9]
The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether [J].
Arunothayanun, P ;
Bernard, MS ;
Craig, DQM ;
Uchegbu, IF ;
Florence, AT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 201 (01) :7-14
[10]
Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: Role of CXCR4 and SDF1 in glioma cell proliferation and migration [J].
Bajetto, Adriana ;
Barbieri, Federica ;
Dorcaratto, Alessandra ;
Barbero, Simone ;
Daga, Antonio ;
Porcile, Carola ;
Ravetti, Jean Louis ;
Zona, Gianluigi ;
Spaziante, Renato ;
Corte, Giorgio ;
Schettini, Gennaro ;
Florio, Tullio .
NEUROCHEMISTRY INTERNATIONAL, 2006, 49 (05) :423-432